Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers
Leonard Kaps, Detlef Schuppan
Cells (2020) Vol. 9, Iss. 9, pp. 2027-2027
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma
Fanhua Kong, Qifa Ye, Xiongying Miao, et al.
Theranostics (2021) Vol. 11, Iss. 11, pp. 5464-5490
Open Access | Times Cited: 128
Targeting CAFs to overcome anticancer therapeutic resistance
Phei Er Saw, Jianing Chen, Erwei Song
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 527-555
Closed Access | Times Cited: 123
Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects
Silvius Stanciu, Florentina Ioniţă‐Radu, Constantin Ștefani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10132-10132
Open Access | Times Cited: 76
Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy
Zhongsong Zhang, Rong Wang, Long Chen
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 483-503
Open Access | Times Cited: 3
Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Zhongsong Zhang, Long Chen
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy
Maurice Stephan Michel, Leonard Kaps, Annett Maderer, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2296-2296
Open Access | Times Cited: 79
Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology
Ernesto Bockamp, Sebastian Rosigkeit, Dominik Siegl, et al.
Cells (2020) Vol. 9, Iss. 9, pp. 2102-2102
Open Access | Times Cited: 75
Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis
Aiting Yang, Yong-Ook Kim, Xuzhen Yan, et al.
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 15, Iss. 4, pp. 841-867
Open Access | Times Cited: 61
Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
Tomoko Tadokoro, Asahiro Morishita, Tsutomu Masaki
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8139-8139
Open Access | Times Cited: 60
Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer
Shulan Han, Shengnan Bi, Tingting Guo, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 250-263
Closed Access | Times Cited: 59
Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma
Jaafar Khaled, Maria Kopsida, Hans Lennernäs, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 632-632
Open Access | Times Cited: 51
Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials
Syed Nasir Abbas Bukhari
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 866-866
Open Access | Times Cited: 47
Drug delivery strategy in hepatocellular carcinoma therapy
Sisi Yang, Chengwei Cai, Huanqiu Wang, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 41
Recent Advances in Glycyrrhetinic Acid-Functionalized Biomaterials for Liver Cancer-Targeting Therapy
Antonio Speciale, Claudia Muscarà, Maria Sofia Molonia, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1775-1775
Open Access | Times Cited: 38
Signaling pathways in liver cancer: pathogenesis and targeted therapy
Yangtao Xue, Yeling Ruan, Yali Wang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 10
Multicompartment Polyion Complex Micelles Based on Triblock Polypept(o)ides Mediate Efficient siRNA Delivery to Cancer‐Associated Fibroblasts for Antistromal Therapy of Hepatocellular Carcinoma
Paul M. Schneider, Heyang Zhang, Leon Simić, et al.
Advanced Materials (2024) Vol. 36, Iss. 41
Closed Access | Times Cited: 10
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
Qiushi Feng, Xiaofeng Shan, Vicky Yau, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 62-62
Open Access | Times Cited: 1
Metastasis-associated fibroblasts: an emerging target for metastatic cancer
Zimu Wang, Jiaxin Liu, Hairong Huang, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 44
pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages
Leonard Kaps, Anne Huppertsberg, Niklas Choteschovsky, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 12
Open Access | Times Cited: 28
Influence of extracellular matrix composition on tumour cell behaviour in a biomimetic in vitro model for hepatocellular carcinoma
Carlemi Calitz, Jenny Rosenquist, Oliver Degerstedt, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 21
The application of nanoparticles in immunotherapy for hepatocellular carcinoma
Xinyao Hu, Hua Zhu, Xiaoqin He, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 85-108
Closed Access | Times Cited: 19
Curcumin Alleviates Aflatoxin B1-Induced Liver Pyroptosis and Fibrosis by Regulating the JAK2/NLRP3 Signaling Pathway in Ducks
Yilong Cui, Qi Wang, Xuliang Zhang, et al.
Foods (2023) Vol. 12, Iss. 5, pp. 1006-1006
Open Access | Times Cited: 17
Multifaced roles of desmoplastic reaction and fibrosis in pancreatic cancer progression: Current understanding and future directions
Hiromichi Sato, Tomoaki Hara, Sikun Meng, et al.
Cancer Science (2023) Vol. 114, Iss. 9, pp. 3487-3495
Open Access | Times Cited: 17
Macrophages and platelets in liver fibrosis and hepatocellular carcinoma
Martina Casari, Dominik Siegl, Carsten Deppermann, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Targeted delivery strategies: The interactions and applications of nanoparticles in liver diseases
Xiandi Meng, Ge Zhu, Yong‐Guang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116702-116702
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top